-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
ZIVO Bioscience (NASDAQ:ZIVOW) Stock Price Up 13%
ZIVO Bioscience (NASDAQ:ZIVOW) Stock Price Up 13%
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) rose 13% during trading on Wednesday . The stock traded as high as $0.85 and last traded at $0.80. Approximately 7,468 shares traded hands during trading, an increase of 191% from the average daily volume of 2,563 shares. The stock had previously closed at $0.71.
ZIVO Bioscience Stock Performance
The firm's 50 day simple moving average is $0.73 and its 200 day simple moving average is $0.78.
Get ZIVO Bioscience alerts:Institutional Inflows and Outflows
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC boosted its position in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,654 shares of the company's stock after buying an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent filing with the Securities & Exchange Commission.
About ZIVO Bioscience
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Further Reading
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Roblox Gains Traction With Metaverse, Shares Pop
- GXO Logistics Manages Another Buying Opportunity
- Arista Networks In Buy Range After Topping Q4 Views
- Analysts Like The Flavor Of Restaurant Brands International
- What is Consumer Discretionary?
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) rose 13% during trading on Wednesday . The stock traded as high as $0.85 and last traded at $0.80. Approximately 7,468 shares traded hands during trading, an increase of 191% from the average daily volume of 2,563 shares. The stock had previously closed at $0.71.
ZIVO 生物科學公司 (納斯達克:自由 — 獲得評級) 上漲 13% 在週三交易期間.該股票的交易價格高達 0.85 美元，最後交易價格為 0.80 美元。交易期間約 7,468 股，較 2,563 股的平均每日成交量增加 191%。該股票以前已收盤 0.71 美元。
ZIVO Bioscience Stock Performance
ZIVO 生物科學股票表現
The firm's 50 day simple moving average is $0.73 and its 200 day simple moving average is $0.78.
該公司的 50 天簡單移動平均線為 0.73 美元，而 200 天的簡單移動平均線為 0.78 美元。
Institutional Inflows and Outflows
機構流入和流出
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC boosted its position in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,654 shares of the company's stock after buying an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent filing with the Securities & Exchange Commission.
一家對沖基金最近籌集了 ZIVO 生物科學股份的股份。根據其最近與證券交易委員會的披露，沃伯格資產管理有限責任公司（NASDAQ：ZIVOW-獲得評級）在第三季度將其在 ZIVO 生物科學公司（NASDAQ：ZIVOW-獲得評級）的股票地位提高了 442.0％。該公司在本季度額外購買 69,034 股股票後持有該公司股票 84,654 股。沃伯格資產管理有限責任公司在 ZIVO 生物科學的持有價值 $51,000 作為其最近的申請與證券交易委員會.
About ZIVO Bioscience
關於滋豐生物科學
(Get Rating)
(取得評分)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc 是一家總部位於密歇根州的生物科技/農業科技公司，致力於利用源自其專有藻類培養物的免疫健康和營養益處。該開發管線包括用作膳食補充劑和功能性食品成分的天然產品，以及創新的，生物衍生和合成的候選物，旨在為人類和動物提供藥用和藥物益處，特別著重於調節免疫和炎症反應。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Roblox Gains Traction With Metaverse, Shares Pop
- GXO Logistics Manages Another Buying Opportunity
- Arista Networks In Buy Range After Topping Q4 Views
- Analysts Like The Flavor Of Restaurant Brands International
- What is Consumer Discretionary?
- 獲取有關 ZIVO 生物科學研究報告的免費副本
- Roblox 通過元宇宙獲得牽引力，股票流行
- GXO 物流管理另一個購買機會
- 阿里斯塔網絡在購買範圍頂部 Q4 視圖
- 分析師喜歡的風味餐廳品牌國際
- 什麼是自由消費品？
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 ZIVO 生物科學日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 ZIVO 生物科學及相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧